Prospera Financial Services Inc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1541625 Dallas, TX

Position in REGN

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$3,605,910

+$92,358 QoQ

Shares Held

4,667

+2.5% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Prospera Financial Services Inc holds $12,879,194 across 15 Biotechnology names. REGN ranks #2 (28.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	77,622	$3,943,197
2	REGN	Regeneron Pharmaceuticals, Inc. This page	4,667	$3,605,910
3	PBYI	Puma Biotechnology, Inc.	173,051	$1,105,795
4	VRTX	Vertex Pharmaceuticals Inc / Ma	2,360	$1,053,834
5	PLX	Protalix BioTherapeutics, Inc.	418,570	$908,296
6	TGTX	Tg Therapeutics, Inc.	20,998	$697,553
7	SRPT	Sarepta Therapeutics, Inc.	17,492	$380,625
8	IONS	Ionis Pharmaceuticals Inc	4,341	$325,965

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,605,910	4,667	+2.5%	Shares	Sole	2026-04-14
2025-12-31	$3,513,552	4,552	-48.1%	Shares	Sole	2026-02-09
2025-09-30	$4,928,858	8,766	-38.0%	Shares	Sole	2025-11-06
2025-06-30	$7,419,825	14,133	+270.7%	Shares	Sole	2025-08-06
2025-03-31	$2,418,318	3,813	+3.1%	Shares	Sole	2025-05-15
2024-12-31	$2,634,196	3,698	+399.7%	Shares	Sole	2025-02-13
2024-09-30	$777,917	740	+23.3%	Shares	Sole	2024-11-07
2022-12-31	$432,894	600	+757.1%	Shares	Sole	2023-02-08
2022-06-30	$41,379	70	+2.9%	Shares	Sole	2022-08-08
2022-03-31	$47,492	68	-51.8%	Shares	Sole	2022-05-04
2020-09-30	$78,928	141	-90.0%	Shares	Sole	2020-11-04
2020-06-30	$874,980	1,403	-30.8%	Shares	Sole	2020-08-10
2020-03-31	$989,763	2,027	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.